A phase 2 trial of the somatostatin analog pasireotide to prevent GI toxicity and acute GVHD in allogeneic hematopoietic stem cell transplant.
Ramalingam S, Siamakpour-Reihani S, Bohannan L, Ren Y, Sibley A, Sheng J, Ma L, Nixon AB, Lyu J, Parker DC, Bain J, Muehlbauer M, Ilkayeva O, Kraus VB, Huebner JL, Spitzer T, Brown J, Peled JU, van den Brink M, Gomes A, Choi T, Gasparetto C, Horwitz M, Long G, Lopez R, Rizzieri D, Sarantopoulos S, Chao N, Sung AD.
Ramalingam S, et al. Among authors: ma l.
PLoS One. 2021 Jun 25;16(6):e0252995. doi: 10.1371/journal.pone.0252995. eCollection 2021.
PLoS One. 2021.
PMID: 34170918
Free PMC article.
Clinical Trial.